About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Services
Drug Substance Manufacturing
Fill & Finish
Gene to Vial: End-to-End Development
Process Development
Analytics
Cell Line Development & Banking
Science Hub
Science News
Resources
News & Events
Press releases
Events
Content to download
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Contact us
Contact form
Contact for investors
Contact for media
Careers
EN
Science News
Resources
Biologics
Biologics CDMO Solutions for the Future of Therapeutics
Biologics
,
Drug development
,
Manufacturing
Bioanalytical Assay Strategies and Considerations for Validation of B Cells-Depletion Assay by Flow Cytometry
Bioanalytics
,
Biologics
Top 5 most expected biologics in 2024
Biologics
,
Drug development
,
EMA
,
FDA
,
Regulatory
Similar but not the same: an in-depth look at the differences between EMA and FDA
Biologics
,
EMA
,
FDA
,
Regulatory
Top 10 biologics approved in 2023
Biologics
,
EMA
,
FDA
,
Monoclonal antibody
,
Vaccines
Development and regulation of veterinary monoclonals
Biologics
,
Drug development
,
Regulatory
,
Veterinary biologics
Impact of immunogenicity on efficacy and safety of biosimilars – importance of ADA and nAb testing during the clinical development
Biologics
,
Drug product
Mycoplasma contamination in biopharmaceutical manufacturing
Biologics
,
Cell culture
,
Contamination
,
Manufacturing
Impact of glycosylation on the effector functions of monoclonal antibodies: a case study of rituximab
Bioanalytics
,
Biologics
,
Drug substance
,
Manufacturing
Previous
1
2
3